A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients.

PURPOSE To develop a hypothesis-generating framework for automatic extraction of dose-outcome relationships from an in-house, analytic oncology database. METHODS Dose-volume histograms (DVH) and clinical outcomes have been routinely stored to the authors' database for 684 head and neck cancer patients treated from 2007 to 2014. Database queries were developed to extract outcomes that had been assessed for at least 100 patients, as well as DVH curves for organs-at-risk (OAR) that were contoured for at least 100 patients. DVH curves for paired OAR (e.g., left and right parotids) were automatically combined and included as additional structures for analysis. For each OAR-outcome combination, only patients with both OAR and outcome records were analyzed. DVH dose points, DVt, at a given normalized volume threshold Vt were stratified into two groups based on severity of toxicity outcomes after treatment completion. The probability of an outcome was modeled at each Vt = [0%, 1%, …, 100%] by logistic regression. Notable OAR-outcome combinations were defined as having statistically significant regression parameters (p < 0.05) and an odds ratio of at least 1.05 (5% increase in odds per Gy). RESULTS A total of 57 individual and combined structures and 97 outcomes were queried from the database. Of all possible OAR-outcome combinations, 17% resulted in significant logistic regression fits (p < 0.05) having an odds ratio of at least 1.05. Further manual inspection revealed a number of reasonable models based on either reported literature or proximity between neighboring OARs. The data-mining algorithm confirmed the following well-known OAR-dose/outcome relationships: dysphagia/larynx, voice changes/larynx, esophagitis/esophagus, xerostomia/parotid glands, and mucositis/oral mucosa. Several surrogate relationships, defined as OAR not directly attributed to an outcome, were also observed, including esophagitis/larynx, mucositis/mandible, and xerostomia/mandible. CONCLUSIONS Prospective collection of clinical data has enabled large-scale analysis of dose-outcome relationships. The current data-mining framework revealed both known and novel dosimetric and clinical relationships, underscoring the potential utility of this analytic approach in hypothesis generation. Multivariate models and advanced, 3D dosimetric features may be necessary to further evaluate the complex relationship between neighboring OAR and observed outcomes.

[1]  R. Frankowski,et al.  The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. , 2001, Archives of otolaryngology--head & neck surgery.

[2]  Di Yan,et al.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. , 2007, International journal of radiation oncology, biology, physics.

[3]  Philippe Lambin,et al.  Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Shivani Kumar,et al.  Comp Plan: A computer program to generate dose and radiobiological metrics from dose-volume histogram files. , 2012, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[5]  Binbin Wu,et al.  An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection. , 2012, Medical physics.

[6]  J. Deasy,et al.  Datamining approaches for modeling tumor control probability , 2010, Acta oncologica.

[7]  Moyed Miften,et al.  EUCLID: an outcome analysis tool for high-dimensional clinical studies , 2007, Physics in medicine and biology.

[8]  Benjamin Movsas,et al.  Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. , 2007, International journal of radiation oncology, biology, physics.

[9]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[10]  David Joseph,et al.  Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial , 2014 .

[11]  Todd McNutt,et al.  Automatic treatment planning implementation using a database of previously treated patients , 2014 .

[12]  E. Yorke,et al.  Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. , 2010, International journal of radiation oncology, biology, physics.

[13]  Joseph O Deasy,et al.  Radiotherapy dose-volume effects on salivary gland function. , 2010, International journal of radiation oncology, biology, physics.

[14]  Steven F Petit,et al.  Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  J. Mechalakos,et al.  Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[16]  J. Deasy,et al.  Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. , 2006, International journal of radiation oncology, biology, physics.

[17]  Joseph O Deasy,et al.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.

[18]  G. Lockwood,et al.  Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. , 2005, International journal of radiation oncology, biology, physics.

[19]  Russell H. Taylor,et al.  Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning. , 2011, International journal of radiation oncology, biology, physics.

[20]  Richard Birtwhistle,et al.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. , 2003, BMC medical research methodology.

[21]  I El Naqa,et al.  Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationships , 2006, Physics in medicine and biology.

[22]  E. Vokes,et al.  The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.

[23]  P. Levendag,et al.  Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  J. Lurie,et al.  Pros and cons of pragmatic clinical trials. , 2013, Journal of comparative effectiveness research.

[25]  Kyriaki Theodorou,et al.  A free software for the evaluation and comparison of dose response models in clinical radiotherapy (DORES) , 2009, International journal of radiation biology.

[26]  Andrzej Niemierko,et al.  A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. , 2007, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[27]  M. Martel,et al.  Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.

[28]  Avraham Eisbruch,et al.  Radiation dose-volume effects in the larynx and pharynx. , 2010, International journal of radiation oncology, biology, physics.

[29]  Sasa Mutic,et al.  Developing a national radiation oncology registry: From acorns to oaks. , 2012, Practical radiation oncology.

[30]  Randall K Ten Haken,et al.  Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. , 2011, International journal of radiation oncology, biology, physics.

[31]  F. Feng,et al.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. , 2007, International journal of radiation oncology, biology, physics.

[32]  D. Vordermark,et al.  The influence of parotid gland sparing on radiation damages of dental hard tissues , 2012, Clinical Oral Investigations.